Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alnylam nets another $20m from Takeda
Bizjournals.com
Tuesday, March 23, 2010 - 11:53am
tags:
Alnylam, Takeda, RNA interference
Simcere's Cancer Drug Makes Significant Headway in Trials
Seeking Alpha
Tuesday, March 23, 2010 - 11:36am
tags:
Simcere, Endostar
Somaxon share offering to fund insomnia drug plan
Yahoo/AP
Tuesday, March 23, 2010 - 11:35am
tags:
insomnia, Somaxon, Silenor, FDA
Greater research costs boots Inhibitex 4Q loss
Yahoo/AP
Tuesday, March 23, 2010 - 11:33am
tags:
Inhibitex, earnings
Surprise FDA Approvals of Rejected Drugs Are No Sign of Mercy
BNET Pharma
Tuesday, March 23, 2010 - 11:19am
tags:
FDA, Silenor, Somaxon
Merck KGaA halts cancer vaccine trial
Yahoo/AP
Tuesday, March 23, 2010 - 11:12am
tags:
Merck KGaA, vaccines, cancer, Stimuvax
Glaxo, Pfizer agree to supply pneumonia vaccines
Yahoo/AP
Tuesday, March 23, 2010 - 11:09am
tags:
GSK, Pfizer, vaccines
Abbott subsidiary starts tender offer for Facet
Yahoo/AP
Tuesday, March 23, 2010 - 10:26am
tags:
Abbott Laboratories, Facet Biotech, M&A
[video]Cramer: Teva - The Generic Edge
TheStreet.com
Tuesday, March 23, 2010 - 10:25am
tags:
Teva Pharmaceuticals, generics
Should The FDA Be Able To Reevalute Products?
Pharmalot
Tuesday, March 23, 2010 - 9:01am
tags:
FDA, Menaflex, ReGen
ChemGenex Shares Plunge After Panel Ruling on Drug
Bloomberg
Tuesday, March 23, 2010 - 8:58am
tags:
ChemGenex, FDA, Omapro, leukemia
Sanofi Rattled by Reports of Negative Drug Review in France
Seeking Alpha
Tuesday, March 23, 2010 - 8:57am
tags:
Sanofi, Multaq, France
AstraZeneca Expands Interest in Emerging Markets
Seeking Alpha
Tuesday, March 23, 2010 - 8:56am
tags:
AstraZeneca, BRIC, Brazil, Russia, India, China
When Plavix May Not Work
WSJ Online
Monday, March 22, 2010 - 6:57pm
tags:
Plavix, blood thinners, Bristol-Myers Squibb, Sanofi
FDA panel rejects Cell Therapeutics drug
Bizjournals.com
Monday, March 22, 2010 - 5:35pm
tags:
FDA, Cell Therapeutics, pixantrone
FDA Calls for Temporary Halt in Use of Glaxo's Rotavirus Vaccine
WSJ Online
Monday, March 22, 2010 - 5:33pm
tags:
FDA, GSK, vaccines, rotavirus, Rotarix
GeoPharma faces delisting
Bizjournals.com
Monday, March 22, 2010 - 5:32pm
tags:
GeoPharma, delisting, NASDAQ
Health-Care ETFs Gain
WSJ Online
Monday, March 22, 2010 - 5:31pm
tags:
ETFs
FDA warns on Glaxo rotavirus vaccine
Marketwatch
Monday, March 22, 2010 - 5:30pm
tags:
GSK, rotavirus, vaccines, Rotarix
The Morning After: Reaction to the House Health-Care Vote
WSJ Online
Monday, March 22, 2010 - 10:59am
tags:
healthcare bill, healthcare reform

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.